Oral peptide combinations in Agent Orange-exposed veterans with immune deficiency
Observational study · 2013
- What was studied
- 150 veterans with immune deficiency in the Joint Vietnam–Russia Program 33. The same 150 are shown before and after treatment.
- Main finding
- In 150 veterans, mean IgG rose from 1,202.27 to 1,445.20 mg/dL and CD4 cells from 501.96 to 569.33 cells/µL (both p<0.01). CD19 and the CD4/CD8 ratio did not change significantly.
Related evidence maps: Military & occupational ↗
Reported findings and study design
The researchers compared immunoglobulins and lymphocyte markers before and after the 20-day regimen. Tables show paired assessment denominators of 150. The reference laboratory column is a population benchmark.
Population or model 150 veterans with immune deficiency in the Joint Vietnam–Russia Program 33. The same 150 are shown before and after treatment.
Dose, route and schedule
Vladoniks, Vezugen and Kristagen were taken orally for 20 days. The paper lists 0.2 g of each preparation. It does not give purified peptide content or capsule frequency.
Protocol source ↗ · Original journal PDF, methods and Tables 1–6. Parent program report and Ministry of Defence project citation checked.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| IgG | 1,202.27 → 1,445.20 mg/dL | Before and after the combination. · p<0.01 |
| CD4 cells | 501.96 → 569.33 cells/µL | p<0.01 |
| IgM | 126.56 → 132.46 mg/dL | p<0.01 |
| CD3 and CD8 cells | 963.01 → 1,088.78 and 389.72 → 438.10 cells/µL | p<0.01 and p<0.05, respectively |
| IgA, CD19 and CD4/CD8 ratio | No statistically significant change | p>0.05 |
| Author-defined overall outcome | 105/150 good, 45/150 fair | No untreated group for this rating. |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- This was a before-and-after study of three products with no concurrent untreated group. Individual product effects and effects on infection risk remain uncertain.
- Program 33 reports 300 participants across two clinical series. The relationship between the two participant lists remains unverified.
Related publications may describe some of the same participants or experiments.
Source details
Original journal PDF, methods and Tables 1–6. Parent program report and Ministry of Defence project citation checked.
Sources checked
Citation
Hoàng Văn Huấn, Phạm Khắc Linh, Nguyễn Như Nghĩa, and colleagues. Oral peptide combinations in Agent Orange-exposed veterans with immune deficiency Journal of Tropical Science and Technology. 2013;(2):78–84.
Related compounds
Vladonix
An oral peptide mixture extracted from calf or pig thymus, studied in Russian immune-function reports.
Vesugen
A synthetic three-amino-acid peptide (Lys–Glu–Asp, or KED) studied in vascular and cell-aging research.
Crystagen
A short-peptide product described in institute reports as containing glutamate, aspartate and proline. The reports do not establish that the tested product was chemically identical to isolated Glu–Asp–Pro (EDP).